PIWIL3 and neoplasm: The combination of OIP5-AS1 knockdown with the over-expression of PIWIL3 and miR-367-3p leads to tumor regression, identifying a novel molecular pathway in glioma cells that may provide a potential innovative approach for cancer therapy [23].